HormonalFDA Approved
Pegvisomant
Somavert
A GH receptor antagonist that blocks growth hormone action. Used for acromegaly when surgery and somatostatin analogs fail to normalize IGF-1. ~90% achieve normal IGF-1.
FDA Approved10-30 mg daily
Peptide Database
Browse Research Peptides
Comprehensive profiles for 105+ peptides — dosing protocols, mechanisms of action, clinical research, and safety data.
105
Peptides
9
Categories
105 peptides · page 4 of 5
HealingPreclinical
Pentadecapeptide
BPC-157 Full Sequence
The full 15-amino acid sequence containing BPC-157, derived from gastric juice with comparable healing properties.
Animal Studies250-500 mcg twice daily
BioregulatorNot FDA Approved
Pinealon
EDR
A synthetic tripeptide bioregulator targeting brain tissue, designed to support cognitive function and neuroprotection as part of Khavinson's peptide research.
Animal Studies10-20 mg daily
HormonalFDA Approved
Plecanatide
Trulance
A uroguanylin analog for chronic constipation and IBS-C, engineered to mimic a naturally occurring peptide. pH-sensitive activation may provide more targeted action in the small intestine.
FDA Approved3 mg once daily
BioregulatorPreclinical
Prostamax
A peptide bioregulator designed to target prostate tissue, part of the five synthesized peptides developed by Khavinson demonstrating effects on gene expression and tissue-specific regulation.
Animal Studies10-20 mg daily
Weight LossIn Clinical Trials
Retatrutide
LY3437943
A triple agonist activating GLP-1, GIP, and glucagon receptors for enhanced weight loss outcomes.
Clinical Trials4-12 mg weekly
Skin & HairNot FDA Approved
SNAP-8
Acetyl Octapeptide-3
A cosmetic peptide that reduces wrinkles by inhibiting muscle contraction. Studies show up to 63% reduction in wrinkle depth over 28 days.
Community3-10% in topical formulations
Anti-AgingFDA Approved
SS-31
Elamipretide
A mitochondria-targeted peptide that improves cellular energy production. FDA approved for Barth syndrome in September 2025.
FDA Approved40 mg subcutaneous daily
CognitiveNot FDA Approved
Selank
Selanc
A synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects.
Clinical Trials250-500 mcg intranasal 2-3x daily
Weight LossFDA Approved
Semaglutide
Ozempic
A GLP-1 receptor agonist with multiple FDA approvals including weight management, type 2 diabetes treatment, cardiovascular risk reduction, and kidney disease protection. 94% amino acid similarity to human GLP-1.
FDA Approved1-2.4 mg weekly (after titration)
Weight LossFDA Approved
Semaglutide Oral
Rybelsus
The first oral GLP-1 receptor agonist FDA approved, using SNAC absorption enhancer. Achieves 80% bioavailability of subcutaneous injection.
FDA Approved3-14 mg daily (titrate up)
CognitiveNot FDA Approved
Semax
SEMAX
Synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Used clinically in Russia for stroke, traumatic brain injury, and cognitive disorders.
Clinical Trials200-600 mcg intranasal daily
Growth HormoneNot FDA Approved
Sermorelin
Geref
A truncated analog of natural GHRH containing the first 29 amino acids, used off-label for hormone optimization.
Animal Studies200-500 mcg before bed
Weight LossFDA Approved
Setmelanotide
Imcivree
An MC4R agonist for rare genetic obesity disorders. FDA approved for specific gene mutations causing obesity.
FDA Approved2-3 mg daily
Weight LossIn Clinical Trials
Survodutide
BI 456906
A dual GLP-1/glucagon receptor agonist being developed for obesity and metabolic dysfunction-associated fatty liver disease (MASH). Phase 2 showed 83% MASH resolution vs 18% placebo.
Clinical TrialsResearch protocols only
HealingPreclinical
TB-500
Thymosin Beta-4 fragment
A synthetic 17-amino acid fragment of Thymosin Beta-4 with a longer half-life (~2-4 days) compared to the full protein (~2 hours).
Animal Studies2-2.5 mg twice weekly (loading), 2.5 mg once weekly (maintenance)
HormonalFDA Approved
Teriparatide
Forteo
A recombinant parathyroid hormone fragment that stimulates bone formation. Demonstrated 65% reduction in vertebral fractures in clinical trials.
FDA Approved20 mcg daily
Growth HormoneFDA Approved
Tesamorelin
Egrifta
An FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy.
FDA Approved2 mg daily (F8: 1.28 mg daily)
BioregulatorPreclinical
Testagen
A peptide bioregulator targeting testicular tissue. Supports healthy testicular function through tissue-specific gene regulation.
Animal Studies10-20 mg daily
BioregulatorNot FDA Approved
Thymalin
Thymic Factor
A thymic peptide complex utilized in Russia for immune enhancement and longevity support, developed through Professor Khavinson's bioregulator peptide research.
Clinical Trials10-20 mg daily for 5-10 days
ImmuneNot FDA Approved
Thymogen
EW Dipeptide
A synthetic dipeptide (Glu-Trp) bioregulator derived from Thymalin, representing one of Professor Khavinson's key immunomodulatory compounds.
Clinical Trials1-2 capsules (10-20 mg) daily
ImmuneNot FDA Approved
Thymosin Alpha-1
Ta1
A naturally occurring thymic peptide that enhances immune function.
Clinical Trials1.6 mg twice weekly
HealingIn Clinical Trials
Thymosin Beta-4
TB-4
The full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues. Has a shorter half-life (~2 hours) compared to TB-500 (~2-4 days).
Clinical Trials2.5-5 mg, 2-3 times weekly
BioregulatorPreclinical
Thyreogen
A peptide bioregulator derived from thyroid tissue containing a complex with glutamic acid, aspartic acid, tyrosine, phenylalanine, proline, and serine.
Animal Studies10-20 mg daily